{"0": ["actavis", "acquisition", "allergan", "latest", "wave", "tie", "ups", "among", "companies", "pharmaceutical", "sector", "bayer", "announced", "may", "buying", "merck's", "consumer", "care", "business", "14.2", "billion", "april", "novartis", "glaxo", "smithkline", "eli", "lilly", "joined", "forces", "28.5", "billion", "deal", "actavis", "buy", "botox", "maker", "allergan", "66b", "actavis", "paying", "billion", "buy", "fellow", "drugmaker", "allergan", "deal", "could", "finally", "end", "months-long", "takeover", "battle", "waged", "valeant", "pharmaceuticals", "botox", "maker"], "1": ["comments", "actavis", "plc", "tuesday", "completed", "acquisition", "allergan", "inc", "agn", "-1.68", "valued", "70.5", "billion", "closing", "biggest", "deal", "ending", "one", "year", "dramatic", "takeover", "battles", "deal", "makes", "actavis", "one", "world", "largest", "drug", "makers", "sales", "offering", "range", "eye", "skin", "stomach", "drugs", "company", "expected", "billion", "sales", "next", "year", "30,000", "employees", "market", "capitalization", "billion", "times", "actavis", "equity", "value", "two", "years", "ago"], "2": ["actavis", "act", "announced", "monday", "buy", "pharmaceutical", "peer", "allergan", "agn", "billion", "deal", "appears", "finally", "thwarted", "efforts", "valeant", "pharmaceuticals", "vrx", "acquire", "botox", "manufacturer", "hostile", "takeover", "acquisition", "valued", "per", "share", "cash", "actavis", "shares", "actavis", "buy", "botox", "maker", "allergan", "66b", "actavis", "paying", "billion", "buy", "fellow", "drugmaker", "allergan", "deal", "could", "finally", "end", "months-long", "takeover", "battle", "waged", "valeant", "pharmaceuticals", "botox", "maker"], "3": ["actavis", "completes", "allergan", "acquisition", "combination", "creates", "one", "fastest", "growing", "dynamic", "pharmaceutical", "companies", "global", "healthcare", "leading", "positions", "eye", "care", "neurosciences", "cns", "medical", "aesthetics", "dermatology", "plast"], "4": ["actavis's", "revenue", "exceed", "21.6", "b", "due", "acquisition", "allergan", "stable", "growth", "y-o-y", "basis", "bring", "valuable", "portfolio", "existing", "actavis's", "drug", "portfolio", "great", "potential", "new", "drug", "developments", "actavis", "plc", "act", "global", "integrated", "specialty", "pharmaceutical", "company", "actavis's", "merger", "allergan", "financed", "actavis's", "existing", "equity", "debt", "new", "equity", "issuance", "beginning", "march", "actavis", "announced", "notes", "issuance", "total", "value", "22b", "increases", "actavis's", "net", "debt"], "5": ["deal", "would", "biggest", "ever", "actavis", "largest", "acquisition", "year", "full", "big", "deals", "eclipsing", "comcast", "billion", "takeover", "time", "warner", "cable", "48.5", "billion", "purchase", "directv", "actavis", "already", "completed", "move", "abroad", "exempt", "new", "treasury", "rules", "able", "pay", "lower", "taxes", "allergan", "international", "sales", "actavis", "already", "took", "advantage", "newfound", "financial", "flexibility", "irish", "company", "year", "acquired", "forest", "laboratories"], "6": ["allergan", "acquisition", "actavis", "name", "change", "edit", "november", "actavis", "announced", "intention", "acquire", "allergan", "manufacturer", "botox", "completion", "deal", "would", "increase", "market", "capitalization", "billion", "march", "actavis", "completed", "acquisition", "allergan", "cash", "equity", "transaction", "valued", "approximately", "70.5", "billion", "june", "allergan", "announced", "would", "acquire", "kythera", "biopharmaceuticals", "around", "2.1", "billion", "june", "company", "completed", "acquisition", "auden", "mckenzie", "holdings", "limited", "\u00a3", "million", "july", "company", "acquired", "start-up", "oculeve", "million"], "7": ["allergan", "shares", "morning", "trading", "news", "deal", "market", "capitalization", "63.6", "billion", "shares", "parsippany", "n", "j", "based", "actavis", "nearly", "market", "capitalization", "64.6", "billion", "combined", "company", "expected", "revenue", "billion", "headed", "actavis", "chief", "executive", "brent", "saunders", "actavis", "executive", "chairman", "paul", "bisaro", "continue", "role", "according", "statement", "companies"]}